Tom McNicholas has written widely on many aspects of urinary disease. He is particularly in demand for teaching on benign prostatic disease and urinary symptoms. He has major interests in the management of prostate cancer, the treatment of urinary stone disease and in making common urological investigations (especially prostatic biopsy) both painless and safer.
He has written over 150 major scientific papers which can be reviewed in the bibliography. Most recently he has been lead author of the chapter on Benign Prostatic Disease in the latest addition of Campbell’s Urology. This 4 volume textbook is the “bible” for urology and is used by urological experts worldwide. He is one of only a small handful of British urologists to have been recognised in this way.




For men seeking advice on which treatment to choose for their urinary symptoms:

I was just reading patient comments on the NHS Choices website for men enquiring about urinary problems (http://www.nhs.uk/Conditions/Prostate-enlargement/Pages/Treatment.aspx) and found those contributions very useful. There were a lot of anxieties expressed. I hope these comments help. Some are for reassurance and the others are to resolve uncertainties.Firstly, TURP can be a brilliantly effective
Read More....
Comments

FDA Authorise Urolift

The U.S. Food and Drug Administration today authorised the marketing of the UroLift system, the first permanent implant to relieve low or blocked urine flow in men age 50 and older with an enlarged prostate.13 September 2013 Read the full press release: Urolift Authorised by FDA
Read More....
Comments

GPs changing you from dutasteride to finasteride! Why? 11 Sept 2013

Many men and their partners are currently asking me why their GP has changed their (often very successful) drug therapy from dutasteride (Avodart) to finasteride (previously known as Proscar but now off patent and so now much cheaper.)I do appreciate the pressure all GPs are under to cut prescribing costs. Everyone has to pay for the errors by the financial sector. However, I think that the
Read More....
Comments

The use of Pro2 PSA with particular reference to men younger than 60 as presented by Tom McNicholas at the AUA Meeting in San Diego, California on 7 May 2013

Prof.Tom McNicholasUncritical use of the standard prostate blood test PSA leads men to have unnecessary biopsies and to over diagnosis and usually over treatment of prostate cancer in many men who may never otherwise have suffered significantly from their cancer.  Nevertheless some prostate cancers are lethal and need to be detected.Therefore, we have explored whether we can we improve the
Read More....
Comments

Tom McNicholas (Consultant Urologist, Lister Hospital, Stevenage) discusses his interests in spotting patients with prostate cancer who do not need treatment and personalising treatment for men. This video is from Trends in Urology & Men's Health Trends in Urology & Men's Health is a journal for healthcare professionals covering all aspects of men's health including prostate disease,
Read More....
Comments
See Older Posts...